Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date
暂无分享,去创建一个
P Sandercock | P. Sandercock | J. Wardlaw | I. Kane | J Wardlaw | I Kane | Peter Sandercock | Joanna Wardlaw | Joanna M. Wardlaw
[1] A. Villringer,et al. Effect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute Stroke <6 Hours , 2002, Stroke.
[2] P. Adeleine,et al. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator , 2004, Journal of the Neurological Sciences.
[3] D. Le Bihan,et al. Correlation between Diffusion- and Perfusion-Weighted MRI and Neurological Deficit Measured by the Scandinavian Stroke Scale and Barthel Index in Hyperacute Subcortical Stroke (≤6 Hours) , 2001, Cerebrovascular Diseases.
[4] Rudolf Graf,et al. The ischemic penumbra , 1994, Current opinion in neurology.
[5] C. Beaulieu,et al. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with clinical outcome , 1999, Annals of neurology.
[6] B. Siewert,et al. Acute human stroke studied by whole brain echo planar diffusion‐weighted magnetic resonance imaging , 1995, Annals of neurology.
[7] À. Rovira,et al. Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol , 2005, Stroke.
[8] J. Wardlaw,et al. Fogging on T2-weighted MR after acute ischaemic stroke: how often might this occur and what are the implications? , 2004, Neuroradiology.
[9] Stephen Rose,et al. Diffusion‐ and perfusion‐weighted MRI response to thrombolysis in stroke , 2002, Annals of neurology.
[10] Sabbir Siddique,et al. Perfusion computed tomography: Prediction of final infarct extent and stroke outcome , 2005, Annals of neurology.
[11] G. Schlaug,et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. , 1999, Neurology.
[12] C. Weiller,et al. Severe ADC Decreases Do Not Predict Irreversible Tissue Damage In Humans , 2002, Stroke.
[13] P. Barber,et al. Refining the Perfusion—Diffusion Mismatch Hypothesis , 2005, Stroke.
[14] Steven Warach,et al. Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era , 2004, Annals of neurology.
[15] S. Warach,et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase , 2005, Stroke.
[16] Roland Bammer,et al. Influence of Arterial Input Function on Hypoperfusion Volumes Measured With Perfusion-Weighted Imaging , 2003, Stroke.
[17] P. Barber,et al. The Use of PWI and DWI Measures in the Design of “Proof‐of‐Concept” Stroke Trials , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[18] P. Barber,et al. Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra , 1999, Neurology.
[19] Jeffry R Alger,et al. Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue , 2003, Stroke.
[20] W Hacke,et al. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia , 2001, Annals of neurology.
[21] K. Schulz,et al. Multiplicity in randomised trials II: subgroup and interim analyses , 2005, The Lancet.
[22] G. Donnan,et al. Perfusion thresholds in acute stroke thrombolysis. , 2003, Stroke.